+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment with large doses of cyclophosphamide of breast cancer with metastases to solid viscera



Treatment with large doses of cyclophosphamide of breast cancer with metastases to solid viscera



Wiadomosci Lekarskie 24(24): 2323-2326




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 044865635

Download citation: RISBibTeXText

PMID: 5139720


Related references

An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer. Breast Cancer Research and Treatment 70(1): 55-63, 2001

An EORTC phase I study of capecitabine (Xeloda) in combination with fixed doses of cyclophosphamide and epirubicin (cex) as primary treatment for large operable or locally advanced/inflammatory breast cancer. European Journal of Cancer 39(9): 1277-1283, 2003

Improved therapeutic effect of sequential immunotherapy with cyclophosphamide, large doses of OK-432 and recombinant interleukin-2 in breast cancer patients with disseminated metastatic liver tumors. Nihon Geka Gakkai Zasshi 92(1): 64-74, 1991

Randomized study of different doses of epirubicin and identical doses of cyclophosphamide in advanced breast cancer. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 1): 32, 1990

Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-Fluorouracil. Oncology Reports 2(4): 577-582, 1995

Different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil: a randomised study in advanced breast cancer. European Journal of Cancer 31a(9): 1549-1551, 1995

Salvage treatment of metastatic breast cancer with sequential cyclophosphamide methotrexate 5 fluorouracil and high doses of folinic acid. Breast Cancer Research & Treatment 6(2): 172, 1985

Lung cancer treatment with high cyclophosphamide doses versus high cyclophosphamide doses plus radiotherapy. International Journal of Radiation Oncology Biology Physics 5(9): 1449-1453, 1979

Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer. Journal of Cancer Research and Clinical Oncology 125(8-9): 500-504, 1999

Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report. Neuro Endocrinology Letters 34(7): 660-668, 2014

Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors. Seminars in Oncology 30(5 Suppl 16): 150-160, 2003

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. Journal of Clinical Oncology 15(5): 1858-1869, 1997

Large doses of methotrexate in the treatment of breast cancer resistant to other types of chemotherapy. Przeglad Lekarski 44(5): 437-439, 1987

Doxorubicin and cyclophosphamide adjuvant chemotherapy is no more effective than cyclophosphamide, methotrexate, and 5-fluorouracil for premenopausal axillary lymph node positive breast cancer: There is no clear evidence that HER-2 status affects the relative effects of doxorubicin and cyclophosphamide vs cyclophosphamide, methotrexate and 5-fluorouracil in women with operable breast cancer. Evidence-Based Oncology 2(2): 83-86, 2001

Cyclophosphamide treatment for metastatic soft tissue sarcoma. Intermittent large doses in the treatment of children. American Journal of Diseases of Children 114(3): 301-308, 1967